Literature DB >> 2497056

Cellobiose/mannitol sugar test--a sensitive tubeless test for coeliac disease: results on 1010 unselected patients.

L D Juby1, J Rothwell, A T Axon.   

Abstract

The cellobiose/mannitol (Ce/Ma) test is a non-invasive technique for investigating intestinal permeability. In coeliac disease there is a decreased absorption of small molecules and paradoxically increased absorption of large molecules. The simultaneous administration of cellobiose and mannitol as two probe molecules allows the permeability of the small bowel mucosa to be studied, eliminating extraneous factors such as gastric emptying, and incomplete urine collection. One thousand and ten patients presenting to a gastroenterology clinic with symptoms, signs, or biochemical indices compatible with coeliac disease had a Ce/Ma test. Eight hundred and seventeen had a normal test and of these 197 had a jejunal biopsy showing 148 normal mucosa, two coeliac disease, 43 non-specific abnormalities, four giardiasis. One hundred and ninety three had an abnormal test; of these 132 had a jejunal biopsy showing 62 normal mucosa, 48 coeliac disease, and 22 other abnormalities. Considering those who had jejunal biopsies, the sensitivity of the test for coeliac disease is 96%, specificity 70%, the predictive value of the positive 36%, and predictive value of the negative 99%. Eleven per cent of the patients with a 'false positive' test had abnormalities in the jejunal biopsy or a diagnosis which could explain the abnormal permeability.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497056      PMCID: PMC1434034          DOI: 10.1136/gut.30.4.476

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Gastrointestinal permeability in food-allergic eczematous children.

Authors:  G C Du Mont; R C Beach; I S Menzies
Journal:  Clin Allergy       Date:  1984-01

Review 2.  The aqueous pore in the red cell membrane: band 3 as a channel for anions, cations, nonelectrolytes, and water.

Authors:  A K Solomon; B Chasan; J A Dix; M F Lukacovic; M R Toon; A S Verkman
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

3.  Small intestinal permeability to sugars in patients with atopic eczema.

Authors:  S O Ukabam; R J Mann; B T Cooper
Journal:  Br J Dermatol       Date:  1984-06       Impact factor: 9.302

4.  Low-molecular-weight polyethylene glycol as a probe of gastrointestinal permeability after alcohol ingestion.

Authors:  G M Robinson; H Orrego; Y Israel; P Devenyi; B M Kapur
Journal:  Dig Dis Sci       Date:  1981-11       Impact factor: 3.199

5.  Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease.

Authors:  S O Ukabam; B T Cooper
Journal:  Dig Dis Sci       Date:  1984-09       Impact factor: 3.199

6.  Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum.

Authors:  S Strobel; W G Brydon; A Ferguson
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

7.  Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon.

Authors:  S O Ukabam; J R Clamp; B T Cooper
Journal:  Digestion       Date:  1983       Impact factor: 3.216

8.  Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.

Authors:  I Bjarnason; P Williams; A So; G D Zanelli; A J Levi; J M Gumpel; T J Peters; B Ansell
Journal:  Lancet       Date:  1984-11-24       Impact factor: 79.321

9.  Cellobiose/mannitol test: physiological properties of probe molecules and influence of extraneous factors.

Authors:  I Cobden; I Hamilton; J Rothwell; A T Axon
Journal:  Clin Chim Acta       Date:  1985-05-15       Impact factor: 3.786

10.  Intestinal permeability in children with Crohn's disease and coeliac disease.

Authors:  A D Pearson; E J Eastham; M F Laker; A W Craft; R Nelson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03
View more
  18 in total

1.  Measurement of small intestinal permeability markers, lactulose, and mannitol in serum: results in celiac disease.

Authors:  M A Cox; K O Lewis; B T Cooper
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

2.  Introduction: a welcome to the First Special Animal Health Issue of AAPS PharmSci.

Authors:  Marilyn Martinez; Stefan Soback
Journal:  AAPS PharmSci       Date:  2002

Review 3.  A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome.

Authors:  Adrienne Lenhart; William D Chey
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

4.  Abnormal permeability precedes the development of a gluten sensitive enteropathy in Irish setter dogs.

Authors:  E J Hall; R M Batt
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

5.  When should the celiac patient have an intestinal biopsy.

Authors:  C Catassi; G Natalini; M Rossini; I M Ratsch; G V Coppa; P L Giorgi
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

6.  Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease.

Authors:  K N Davies; D King; D Billington; J A Barrett
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

7.  Celiac Disease and Dermatitis Herpetiformis: National survey indicates delays in diagnosis.

Authors:  A G Davidson; J A Campbell
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

8.  Small intestinal permeability and orocaecal transit time in cystic fibrosis.

Authors:  A M Dalzell; N S Freestone; D Billington; D P Heaf
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

9.  Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters.

Authors:  Luigi Caserta; Laura de Magistris; Mario Secondulfo; Giancarlo Caravelli; Gabriele Riegler; Giovanna Cuomo; Salvatore D'Angelo; Caterina Naclerio; Gabriele Valentini; Romano Carratù
Journal:  Rheumatol Int       Date:  2003-02-15       Impact factor: 2.631

10.  ACG clinical guidelines: diagnosis and management of celiac disease.

Authors:  Alberto Rubio-Tapia; Ivor D Hill; Ciarán P Kelly; Audrey H Calderwood; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2013-04-23       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.